AI Article Synopsis

  • The study explored how a cell line from the spruce budworm reacts to the hormones 20-hydroxyecdysone (20E) and tebufenozide (RH-5992), showing signs of clumping, filament growth, and increased stress responses.
  • The cell line serves as a valuable model for understanding how ecdysone and its mimics function.
  • Over time, the cells adapted to these hormones and demonstrated reduced toxicity effects, indicating they could minimize harm from these compounds.

Article Abstract

The morphological and molecular responses of a midgut-derived cell line of the spruce budworm, Choristoneura fumiferana, to 20-hydroxyecdysone (20E) and the nonsteroidal ecdysone agonist, tebufenozide (RH-5992), were investigated. The cells responded to these compounds by clumping, generating filamentous extensions, increased mortality and expression of the transcription factor, Choristoneura hormone receptor 3 (CHR3). This cell line can be used as a model system to study the mode of action of ecdysone and its agonists. With subsequent passaging in ecdysteroid-containing medium, the degree of clumping increased and the clumping could not be reversed by subculturing in ecdysteroid-free medium. Cell numbers of the adapted cell lines in 20E and RH-5992 containing media were not significantly decreased, compared to the control, but both cell lines accumulated less (14)C-labeled RH-5992 and lost the capability of expressing CHR3 in response to these compounds. Taken together, the cell lines appeared to develop a mechanism to adapt to the toxic effects of these compounds. Arch. Insect Biochem. Physiol. 55:68-78, 2004.

Download full-text PDF

Source
http://dx.doi.org/10.1002/arch.10124DOI Listing

Publication Analysis

Top Keywords

cell lines
12
morphological molecular
8
agonist tebufenozide
8
midgut-derived cell
8
cell spruce
8
spruce budworm
8
budworm choristoneura
8
choristoneura fumiferana
8
cell
7
molecular effects
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!